Next-Gen Rapid Testing and Point-of-Care Diagnosis for Oral Pathogens (R43/R44)

Post Date

July 1st 2014

Application Due Date

November 20th 2014

Funding Opportunity Number

RFA-DE-15-002

CFDA Number(s)

93.121

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

Small Businesses

Other Eligible Applicants include the following: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. A small business concern is one that, at the time of award of Phase I and Phase II, meets all of the following criteria: 1. Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; 2. Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture; 3.Ф(i) SBIR and STTR.ФBe a concern which is more than 50 percent directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50 percent directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), or any combination of these; OR (ii) SBIR-only.ФBe a concern which is more than 50 percent owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these.ФNo single venture capital operating company, hedge fund, or private equity firm may own more than 50 percent of the concern; OR (iii) SBIR and STTR.ФBe a joint venture in which each entity to the joint venture must meet the requirements set forth in paragraph 3 (i) or 3 (ii) of this section. A joint venture that includes one or more concerns that meet the requirements of paragraph (ii) of this section must comply with _ 121.705(b) concerning registration and proposal requirements. 4.ФHas, including its affiliates, not more than 500 employees.

Funding

• Estimated Total Funding:

  $2000000

• Award Range:

  $None - $None

Grant Description

The goal of this SBIR Funding Opportunity Announcement (FOA) is to encourage research to develop the next-generation of rapid tests and point-of-care (POC) diagnostic devices.These tools must use oral biospecimens for detecting oral pathogens and biomarkers of associated oral diseases to facilitate their screening, monitoring and diagnosis.The ultimate goal is to produce highly reliable, reproducible, specific and sensitive tools for early detection and diagnosis of oral diseases, including those associated with HIV/AIDS.These methods must demonstrate superior technical performance compared with current technologies while not increasing costs and minimizing the invasiveness of specimen collection from patients.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-15-002.html